Submissions from 2017
Adverse Events and Treatment Discontinuations of Antimuscarinics for the Treatment of Overactive Bladder in Older Adults: A Systematic Review and Meta-Analysis, Scott Martin Vouri, Clark D. Kebodeaux, Paul M. Stranges, and Besu F. Teshome
Targeting the PD-1 Pathway in Pediatric Solid Tumors and Brain Tumors, Lars M. Wagner and Val R. Adams
Submissions from 2016
Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical Methodologies, Joshua D. Brown and Val R. Adams
Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma, Joshua D. Brown, Val R. Adams, and Daniela C. Moga
The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population, Joshua D. Brown, Nathan J. Pauly, and Jeffery C. Talbert
Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery, Sara E. Parli, Melissa L. Thompson Bastin, and Daniel A. Lewis
National Trends in Off-Label Use of Atypical Antipsychotics in Children and Adolescents in the United States, Minji Sohn, Daniela C. Moga, Karen Blumenschein, and Jeffery C. Talbert
Inadequate Sedation During Therapeutic Paralysis: Use of Bispectral Index in Critically Ill Patients, Chelsea L. Tasaka, Jeremiah J. Duby, Komal Pandya, Machelle D. Wilson, and Kimberly A. Hardin
Submissions from 2015
Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy, Megan E. Kunka, Elizabeth A. Cady, Heejung C. Woo, and Melissa L. Thompson Bastin
B Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice, Michael M. Opata, Melissa L. Hollifield, Frances E. Lund, Troy D. Randall, Robert Dunn, Beth A. Garvy, and David J. Feola
A Coming Disruption in Pharmacy?, Frank Romanelli and Timothy S. Tracy
Utilizing Monte Carlo Simulations to Optimize Institutional Empiric Antipseudomonal Therapy, Sarah J. Tennant, Donna R. Burgess, Jeffrey M. Rybak, Craig A. Martin, and David S. Burgess
Prescription Drug Monitoring Program Utilization in Kentucky Community Pharmacies, Sarah E. Wixson, Karen Blumenschein, Amie J. Goodin, Jeffery Talbert, and Patricia R. Freeman
Azithromycin Drives Alternative Macrophage Activation and Improves Recovery and Tissue Sparing in Contusion Spinal Cord Injury, Bei Zhang, William M. Bailey, Timothy J. Kopper, Michael B. Orr, David J. Feola, and John C. Gensel
Submissions from 2014
Pharmacy Law Brief: Alternative Dispute Resolution, Joseph L. Fink III
Pharmacy Law Brief: Implications of Being a Specialist, Joseph L. Fink III
Pharmacy Law Brief: Medications and Lawful Executions, Joseph L. Fink III
Pharmacy Law Brief: The Federal False Claims Act, Joseph L. Fink III
A Word of Caution Regarding Proposed Benefits of Albumin from ALBIOS: A Dose of Healthy Skepticism, Alexander H. Flannery, Sean P. Kane, and Angel O. Coz-Yataco
A Filtration System That Greatly Reduces Aluminum in Calcium Gluconate Injection, USP Used to Prepare Parenteral Nutrition Solutions, Robert A. Yokel, Wesley R. Harris, Christopher D. Spilling, Vasiliy P. Abramov, Jason M. Lone, and Robert J. Kuhn
Submissions from 2013
Pharmacy Law Brief: Contemporary Legal Issues for Leadership in Non-Profits - III, Joseph L. Fink III
Pharmacy Law Brief: Contemporary Legal Issues for Leadership in Non-Profits - IV, Joseph L. Fink III
Pharmacy Law Brief: Exclusion of Practitioners from Federally Funded Health Programs, Joseph L. Fink III
Pharmacy Law Brief: National Practitioner Data Bank - What Is It?, Joseph L. Fink III
Pharmacy Law Brief: Pharmacy Law Exam for Licensure, Joseph L. Fink III
